Chicago Partners Investment Group LLC Increases Stake in IQVIA Holdings Inc. $IQV

Chicago Partners Investment Group LLC raised its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 103.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,950 shares of the medical research company’s stock after buying an additional 1,500 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in IQVIA were worth $465,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of the stock. Mather Group LLC. grew its position in shares of IQVIA by 83.5% during the first quarter. Mather Group LLC. now owns 769 shares of the medical research company’s stock valued at $136,000 after purchasing an additional 350 shares in the last quarter. Patton Fund Management Inc. purchased a new position in IQVIA during the 2nd quarter valued at approximately $231,000. Verdence Capital Advisors LLC purchased a new position in shares of IQVIA in the second quarter valued at $3,612,000. Private Advisor Group LLC grew its holdings in shares of IQVIA by 11.6% in the first quarter. Private Advisor Group LLC now owns 5,435 shares of the medical research company’s stock valued at $958,000 after purchasing an additional 566 shares in the last quarter. Finally, Nordea Investment Management AB grew its holdings in shares of IQVIA by 41.7% in the second quarter. Nordea Investment Management AB now owns 2,060,460 shares of the medical research company’s stock valued at $326,274,000 after purchasing an additional 606,391 shares in the last quarter. 89.62% of the stock is owned by hedge funds and other institutional investors.

IQVIA Stock Down 0.3%

Shares of IQV opened at $218.04 on Thursday. The firm has a market capitalization of $37.07 billion, a P/E ratio of 31.55, a P/E/G ratio of 2.40 and a beta of 1.32. IQVIA Holdings Inc. has a 12-month low of $134.65 and a 12-month high of $231.34. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 2.45. The firm has a fifty day moving average price of $193.27 and a 200-day moving average price of $170.28.

IQVIA (NYSE:IQV) last released its quarterly earnings data on Tuesday, July 22nd. The medical research company reported $2.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.77 by $0.04. The company had revenue of $4.02 billion during the quarter, compared to analysts’ expectations of $3.96 billion. IQVIA had a net margin of 7.88% and a return on equity of 30.05%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.64 EPS. Equities research analysts expect that IQVIA Holdings Inc. will post 10.84 earnings per share for the current year.

Wall Street Analyst Weigh In

IQV has been the subject of a number of recent research reports. Barclays lifted their price objective on shares of IQVIA from $185.00 to $200.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 2nd. Mizuho lifted their price target on IQVIA from $190.00 to $225.00 and gave the stock an “outperform” rating in a research report on Friday, July 25th. Robert W. Baird lifted their price target on IQVIA from $159.00 to $196.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 23rd. Evercore ISI lifted their price target on IQVIA from $220.00 to $240.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of IQVIA in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $234.57.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.